Carotid stenting: An open question

Recent controversy over carotid stenting addressed by top interventionalists at TCT 2006 press conference

WASHINGTON, DC, October 24, 2006 Two recent European studies have raised concerns about the safety and efficacy of carotid stenting in symptomatic patients, but leading interventionalists say it's still an open question, and will address the issue at a special press conference Wednesday at the Transcatheter Cardiovascular Therapeutics Symposium (TCT 2006). The panel of experts will address pressing questions, including:

  • Why is carotid stenting being proposed as an alternative to surgery?

  • What is the status of carotid stenting today?

  • What are the data from the two European trials (The French EVA-3S study and German SPACE trial)?

  • What do the European trials tell us about carotid stenting on symptomatic patients?

  • What are the weaknesses and pitfalls of the two recent trials?

  • What is being done in the U.S. to answer questions about carotid stenting as an alternative to carotid surgery?

  • When can we expect definitive answers from U.S. trials?

WHEN: Wednesday, October 25, 12:30-1:00 p.m.

WHERE: TCT 2006 at the Washington Convention Center
Press Briefing Room 159A

CALL-IN #: Press can participate by phone by calling 877-425-3373 in the U.S. or 706-679-4937 internationally. The conference ID number is 9683722.

WHO: The press conference will be moderated by William A. Gray, M.D., Director of Endovascular Services at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Associate Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons. The press conference panelists will be:

  • L. Nelson Hopkins, M.D., Professor of Neurosurgery and Radiology and Chairman of Neurosurgery at the University at Buffalo, State University of New York

  • Subbarao Myla, M.D., Medical Director, Fountain Valley Heart and Vascular Center

  • Klaus Mathias, M.D., Clinic Center Middle Dortmund, Dortmund, Germany

  • Jay Yadav, M.D., Chairman of CardioMEMS Inc.

  • Michael Jaff, D.O., F.A.C.C., Massachusetts General Hospital


Last reviewed: By John M. Grohol, Psy.D. on 30 Apr 2016
    Published on All rights reserved.